- “Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny
- Deregulating the FDA: Back to thalidomide?
- Providing Light on the Sunshine Act
- How fast to “cures” and at what cost? Politico forum tilts toward pharma-friendly messaging
- The 21st Century Cures Act: More Homework To Do
- Regulating Antibiotics in an Era of Resistance: The Historical Basis and
Continued Need for Adequate and Well-Controlled Investigations - “Potential biomarker that could predict”? – caveats about psychiatric brain imaging & blogging about it
- NPA FDA Task Force Testimony Before the Anti-Infective Drug Advisory Committee
- FDA Draft Guidance on the Distribution of Risk Information by Pharmaceutical Companies Falls Short of Ensuring Patient Safety
- Putting Patients First In Congress: A Lobbying Experience
- Antibiotics to patients: too much, too often
- FDA-Approved: Protecting the Legacy of Heroes
Barbara Meier schreibt seit vielen Jahren für die NPAlliance Ratgeber und Testberichte. Dabei legt sie großen Wert auf die Ausführlichkeit sowie Richtigkeit ihrer Artikel. Sie zählt zu den wenigen Experten in ihrem Gebiet und hat sich über die letzten Jahren einen Namen in der Gesundheitsbranche gemacht.